Ingelvac PCV FLEX

RSS

Porcine circovirus vaccine (inactivated)

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR) for Ingelvac PCV Flex.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Ingelvac PCV Flex.

For practical information about using Ingelvac PCV Flex, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 30/11/2017

Authorisation details

Product details
Name
Ingelvac PCV FLEX
Agency product number
EMEA/V/C/004645
Active substance
porcine circovirus type 2 ORF2 protein
International non-proprietary name (INN) or common name
Porcine circovirus vaccine (inactivated)
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI09AA07
Publication details
Marketing-authorisation holder
Boehringer Ingelheim Vetmedica GmbH
Revision
2
Date of issue of marketing authorisation valid throughout the European Union
24/05/2017
Contact address
Binger Strasse 173
55216 Ingelheim am Rhein
Germany

Product information

24/11/2017 Ingelvac PCV FLEX - EMEA/V/C/004645 - IG/0855/G

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Immunologicals for suidae

Therapeutic indication

For active immunisation of pigs with no PCV2 maternally derived antibodies from the age of 2 weeks against porcine circovirus type 2 (PCV2)

Assessment history

How useful was this page?

Add your rating